The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Sex-Based Differences in the Effect of Digoxin for the Treatment of Heart Failure
Abstract
BACKGROUND: The Digitalis Investigation Group trial reported that treatment with digoxin did not decrease overall mortality among patients with heart failure and depressed left ventricular systolic function, although it did reduce hospitalizations slightly. Even though the epidemiologic features, causes, and prognosis of heart failure vary between men and women, sex-based differences in the effect of digoxin were not evaluated. METHODS: We conducted a post hoc subgroup analysis to assess whether there were sex-based differences in the effect of digoxin therapy among the 6800 patients in the Digitalis Investigation Group study. The presence of an interaction between sex and digoxin therapy with respect to the primary end point of death from any cause was evaluated with the use of Mantel-Haenszel tests of heterogeneity and a multivariable Cox proportional-hazards model, adjusted for demographic and clinical variables. RESULTS: There was an absolute difference of 5.8 percent (95 percent confidence interval, 0.5 to 11.1) between men and women in the effect of digoxin on the rate of death from any cause (P=0.034 for the interaction). Specifically, women who were randomly assigned to digoxin had a higher rate of death than women who were randomly assigned to placebo (33.1 percent vs. 28.9 percent; absolute difference, 4.2 percent, 95 percent confidence interval, -0.5 to 8.8). In contrast, the rate of death was similar among men randomly assigned to digoxin and men randomly assigned to placebo (35.2 percent vs. 36.9 percent; absolute difference, -1.6 percent; 95 percent confidence interval, -4.2 to 1.0). In the multivariable analysis, digoxin was associated with a significantly higher risk of death among women (adjusted hazard ratio for the comparison with placebo, 1.23; 95 percent confidence interval, 1.02 to 1.47), but it had no significant effect among men (adjusted hazard ratio, 0.93; 95 percent confidence interval, 0.85 to 1.02; P=0.014 for the interaction). CONCLUSIONS: The effect of digoxin therapy differs between men and women. Digoxin therapy is associated with an increased risk of death from any cause among women, but not men, with heart failure and depressed left ventricular systolic function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The effect of digoxin on mortality and morbidity in patients with heart failure
(1997) · New England Journal of Medicine · doi:10.1056/nejm199702203360801 · Cited by 3,016
The epidemiology of heart failure: The Framingham Study
Ho, K. K. L., Pinsky, J. L., Kannel, W. B., & Levy, D. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90455-a · Cited by 2,247
The progression from hypertension to congestive heart failure
Levy, D. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03530440037034 · Cited by 2,155
Hunt, S. A., Baker, D. W., Chin, M. H., Cinquegrani, M. P., Feldman, A. M., Francis, G. S., Ganiats, T. G., Goldstein, S., Gregoratos, G., Jessup, M. L., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01683-7 · Cited by 1,912
Survival after the onset of congestive heart failure in Framingham Heart Study subjects.
Ho, K. K., Anderson, K. M., Kannel, W. B., Grossman, W., & Levy, D. (1993) · Circulation · doi:10.1161/01.cir.88.1.107 · Cited by 1,869
Guidelines for the diagnosis and treatment of chronic heart failure
Remme, W. (2001) · European Heart Journal · doi:10.1053/euhj.2001.2783 · Cited by 1,592
Committee Members, Hunt, S. A., Baker, D. W., Chin, M. H., Cinquegrani, M. P., Feldmanmd, A. M., Francis, G. S., Ganiats, T. G., Goldstein, S., Gregoratos, G., et al. (2001) · Circulation · doi:10.1161/hc4901.102568 · Cited by 1,442
Subgroup analysis and other (mis)uses of baseline data in clinical trials
Assmann, S. F., Pocock, S. J., Enos, L. E., & Kasten, L. E. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02039-0 · Cited by 1,167
Yusuf, S. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03470010097038 · Cited by 1,014
A consumer's guide to subgroup analyses
Oxman, A. D., & Guyatt, G. H. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-1-78 · Cited by 914
Prevalence and mortality rate of congestive heart failure in the United States
Schocken, D. D., Arrieta, M. I., Leaverton, P. E., & Ross, E. A. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90094-4 · Cited by 817
Representation of the Elderly, Women, and Minorities in Heart Failure Clinical Trials
Heiat, A., Gross, C. P., & Krumholz, H. M. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.15.1682 · Cited by 723
Self-citationStatistical Problems in the Reporting of Clinical Trials
Pocock, S. J., Hughes, M. D., & Lee, R. J. (1987) · New England Journal of Medicine · doi:10.1056/nejm198708133170706 · Cited by 662
Exploring the Biological Contributions to Human Health: Does Sex Matter?
(2001) · National Academies Press eBooks · doi:10.17226/10028 · Cited by 653
Brookes, S. T., Whitley, E., Peters, T. J., Mulheran, P. A., Egger, M., & Davey Smith, G. (2001) · Health Technology Assessment · doi:10.3310/hta5330 · Cited by 580
Sex-associated differences in left ventricular function in aortic stenosis of the elderly.
Carroll, J. D., Carroll, E. P., Feldman, T., Ward, D. M., Lang, R. M., McGaughey, D., & Karp, R. B. (1992) · Circulation · doi:10.1161/01.cir.86.4.1099 · Cited by 488
Heart Failure Society Of America (1999) · Journal of Cardiac Failure · doi:10.1016/s1071-9164(99)91340-4 · Cited by 336
Relation Between Gender, Etiology and Survival in Patients With Symptomatic Heart Failure
Adams, K. F., Dunlap, S. H., Sueta, C. A., Clarke, S. W., Patterson, J. H., Blauwet, M. B., Jensen, L. R., Tomasko, L., & Koch, G. (1996) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00380-4 · Cited by 291
Croft, J. B., Giles, W. H., Pollard, R. A., Keenan, N. L., Casper, M. L., & Anda, R. F. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.5.505 · Cited by 240
Rich, M. W., McSherry, F., Williford, W. O., & Yusuf, S. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01442-5 · Cited by 202
Gender Influences on Sarcoplasmic Reticulum Ca2+-handling in Failing Human Myocardium
Dash, R., Frank, K. F., Carr, A. N., Moravec, C. S., & Kranias, E. G. (2001) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2001.1394 · Cited by 171
Freemantle, N. (2001) · BMJ · doi:10.1136/bmj.322.7292.989 · Cited by 169
Schaible, T. F., Malhotra, A., Ciambrone, G., & Scheuer, J. (1984) · Circulation Research · doi:10.1161/01.res.54.1.38 · Cited by 166
Petrie, M. C., Dawson, N., Murdoch, D. R., Davie, A. P., & McMurray, J. J. V. (1999) · Circulation · doi:10.1161/01.cir.99.17.2334 · Cited by 164
A nomogram for digoxin therapy
Jelliffe, R. W., & Brooker, G. (1974) · The American Journal of Medicine · doi:10.1016/0002-9343(74)90769-4 · Cited by 149
Remodeling of Kv4.3 Potassium Channel Gene Expression under the Control of Sex Hormones
Song, M., Helguera, G. F., Eghbali, M., Ning, Z. H., Zarei, M. M., Olcese, R., Toro, L., & Stefani, E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101058200 · Cited by 137
Kadokami, T., McTiernan, C. F., Kubota, T., Frye, C. S., & Feldman, A. M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9307 · Cited by 136
The Digitalis Investigation Group (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00065-8 · Cited by 133
Patient subsets and variation in therapeutic efficacy.
Simon, R. M. (1982) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1982.tb02015.x · Cited by 130
Gender-Related Differences in Myocyte Remodeling in Progression to Heart Failure
Tamura, T., Said, S., & Gerdes, A. M. (1999) · Hypertension · doi:10.1161/01.hyp.33.2.676 · Cited by 126
Lindenfeld, J. M., Krause-Steinrauf, H. J., & Salerno, J. C. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00343-4 · Cited by 107
Statistics notes: Interaction 3: How to examine heterogeneity: Table 1
Matthews, J. N. S., & Altman, D. G. (1996) · BMJ · doi:10.1136/bmj.313.7061.862 · Cited by 98
Estimation issues in clinical trials and overviews
Pocock, S., & Hughes, M. D. (1990) · Statistics in Medicine · doi:10.1002/sim.4780090612 · Cited by 87
Subgroup Interactions in the Heart and Estrogen/Progestin Replacement Study: Lessons Learned
Furberg, C. D., Vittinghoff, E., Davidson, M., Herrington, D. M., Simon, J. A., WENGER, N. K., & Hulley, S. B. (2002) · Circulation · doi:10.1161/hc0802.104280 · Cited by 74
Analysis of clinical trial outcomes: Some comments on subgroup analyses
Buyse, M. E. (1989) · Controlled Clinical Trials · doi:10.1016/0197-2456(89)90057-3 · Cited by 61
Riemer, R. K., Wu, Y. Y., Bottari, S. P., et al. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13308-7 · Cited by 56
Differences in skeletal muscle between men and women with chronic heart failure
Duscha, B. D., Annex, B. H., Keteyian, S. J., Green, H. J., Sullivan, M. J., Samsa, G. P., Brawner, C. A., Schachat, F. H., & Kraus, W. E. (2001) · Journal of Applied Physiology · doi:10.1152/jappl.2001.90.1.280 · Cited by 41
Gender-related differences in proliferative response of cardiac fibroblasts to hypoxia
Griffin, M., Lee, H.-W., Zhao, L., & Eghblai-Webb, M. (2000) · Molecular and Cellular Biochemistry · doi:10.1023/a:1026585420021 · Cited by 38
Gender‐Related Differences in Modulation of Heart Rate in Patients with Congestive Heart Failure
Aronson, D., & Burger, A. J. (2000) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2000.tb01750.x · Cited by 36
Women, Heart Failure, and Heart Failure Therapies
Wenger, N. K. (2002) · Circulation · doi:10.1161/01.cir.0000014121.94868.81 · Cited by 29
Moyé, L. A. (2001) · Circulation · doi:10.1161/hc2501.090955 · Cited by 15
Cited by
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
Hunt, S. A. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.08.022 · Cited by 4,154
2005 WRITING COMMITTEE MEMBERS, Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.192065 · Cited by 3,720
WRITING COMMITTEE MEMBERS, Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.167586 · Cited by 2,251
ESC Guidelines on the management of cardiovascular diseases during pregnancy
Endorsed by the European Society of Gynecology (ESG), T. A. F. E. P. C. (., Authors/Task Force Members, Regitz-Zagrosek, V., Blomstrom Lundqvist, C., Borghi, C., Cifkova, R., Ferreira, R., Foidart, J.-M., Gibbs, J. S. R., Gohlke-Baerwolf, C., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr218 · Cited by 1,924
Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., Michl, K., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.11.013 · Cited by 1,374
Metadata
- Authors
- Rathore, S. S., Wang, Y., & Krumholz, H. M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2002-10-31
- Volume
- 347
- Issue
- 18
- Pages
- 1403-1411
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2023582771
- Cited by
- 690
- References
- 41
- FWCI
- 24.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.